Oren Abramson

Summary

Affiliation: Kaiser Permanente
Country: USA

Publications

  1. doi request reprint Incidence, prevalence, and time trends of pediatric inflammatory bowel disease in Northern California, 1996 to 2006
    Oren Abramson
    Division of Pediatric Gastroenterology, Kaiser Permanente Northern California, Santa Clara, CA 95051, USA
    J Pediatr 157:233-239.e1. 2010
  2. doi request reprint Patterns of infliximab use among Crohn's disease patients in a community setting
    Alice R Pressman
    Division of Research, Kaiser Permanente Northern California, Oakland, California 94612, USA
    Inflamm Bowel Dis 14:1265-72. 2008
  3. doi request reprint The incidence of hepatosplenic T-cell lymphoma in a large managed care organization, with reference to anti-tumor necrosis factor therapy, Northern California, 2000-2006
    Lisa J Herrinton
    Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA
    Pharmacoepidemiol Drug Saf 21:49-52. 2012
  4. doi request reprint Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005
    Lisa J Herrinton
    Division of Research, Kaiser Permanente Northern California, Oakland, California 94612, USA
    Gastroenterology 137:502-11. 2009

Detail Information

Publications4

  1. doi request reprint Incidence, prevalence, and time trends of pediatric inflammatory bowel disease in Northern California, 1996 to 2006
    Oren Abramson
    Division of Pediatric Gastroenterology, Kaiser Permanente Northern California, Santa Clara, CA 95051, USA
    J Pediatr 157:233-239.e1. 2010
    ..To examine the incidence and prevalence of pediatric inflammatory bowel disease (IBD) during 1996-2006 in a community-based health-care delivery system...
  2. doi request reprint Patterns of infliximab use among Crohn's disease patients in a community setting
    Alice R Pressman
    Division of Research, Kaiser Permanente Northern California, Oakland, California 94612, USA
    Inflamm Bowel Dis 14:1265-72. 2008
    ..We sought to understand predictors of initiation and discontinuation of infliximab in the community-based setting of Kaiser Permanente, Northern California, which provides integrated care to its members...
  3. doi request reprint The incidence of hepatosplenic T-cell lymphoma in a large managed care organization, with reference to anti-tumor necrosis factor therapy, Northern California, 2000-2006
    Lisa J Herrinton
    Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA
    Pharmacoepidemiol Drug Saf 21:49-52. 2012
    ..To better understand this relationship, we conducted an epidemiologic study in the Kaiser Permanente membership...
  4. doi request reprint Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005
    Lisa J Herrinton
    Division of Research, Kaiser Permanente Northern California, Oakland, California 94612, USA
    Gastroenterology 137:502-11. 2009
    ..The management of inflammatory bowel disease (IBD) has become increasingly complicated, and it is unknown whether poor outcomes (prolonged steroid use, hospitalizations, and surgery) have declined in the general population...